Abstract 17172: GDF11 Worsens Myocardial Infarction Outcome in Ischemia and Reperfusion Mouse Model
Alexander Akhmedov(University of Zurich), T F Luescher(Imperial College London), Ariane Schaub Clerigué(University of Zurich), Candela Díaz-Cañestro(University of Zurich), Fabrizio Montecucco(Ospedale Policlinico San Martino), Sarah Costantino(Sapienza University of Rome), Francesco Paneni(University of Zurich), Giovanni G. Camici(University of Zurich), Nicole R. Bonetti(University Hospital Zurich), François Mach(University of Geneva), Daria Vdovenko(University of Zurich)
Circulation
November 14, 2017
Cited by 0
Related Papers
Rosuvastatin in Older Patients with Systolic Heart Failure
|New England Journal of Medicine|2007|1.5k
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
|European Heart Journal|2013|1.4k
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
|The Lancet|2020|747
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis
|Proceedings of the National Academy of Sciences|1997|735